Google Cloud has unveiled two new AI-powered life sciences solutions, Target & Lead Identification Suite and Multiomics Suite, to accelerate drug discovery and precision medicine. These tools leverage machine learning and data analytics to assist researchers and healthcare providers in their efforts to develop innovative treatments and personalized healthcare approaches. The Target & Lead Identification Suite helps research teams identify amino acid function and predict protein structure, while the Multiomics Suite assists researchers in interpreting genomics and multiomics data. Leveraging machine learning algorithms, these Google Cloud tools are able to identify patterns, predict potential drug interactions, and make personalized treatment recommendations.
Previous ArticleChatgpt Predicts Ethereum Will Rise To $50k By The End Of 2023
Next Article South Africa’s Biggest Banks Are Hiring